medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Number 2

<< Back Next >>

Salud Mental 2014; 37 (2)

Thyroid status in lithium-treated bipolar disorder patients: An one-year follow-up study

Cantürk G, Fistikci N, Saatcioglu O, Erten E, Öner S, Turan N

Language: English
References: 37
Page: 139-144
PDF size: 259.21 Kb.


ABSTRACT

Objective: In this follow-up study, the hormonal changes were determined in bipolar euthyroid patients who were treated with lithium for the duration of one year.
Method: For the study, 23 bipolar I disorder patients without any axis I comorbidity were consecutively selected and followed up for one year. All patients were compared with 25 age- and sex-matched healthy controls in terms of thyroid hormone levels and thyroid volumes. The Sociodemographic and Clinical Characteristics Data Form, Hamilton Depression Rating Scale (HAM-D), Young Mania Rating Scale (YMRS), Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I and SCID-I/NP) were administered. Initial thyroid hormone levels and thyroid volumes were measured in the patients and controls. Patient and control groups were compared at baseline for thyroid volumes. Patients’ lithium levels were measured at baseline, they were re-examined at six months for thyroid hormones, and at the first year for thyroid hormones and lithium levels.
Results: Thyroid hormone levels changed in no patients during the follow-up period. Thyroid hormone levels were measured within the normal range. No correlation was found between the final TSH levels and duration of illness, duration of lithium treatment, initial thyroid volumes, and the initial TSH levels.
Conclusions: Lithium can safely be used in bipolar patients who were already receiving this treatment before and not developed any thyroid problem for a substantial period.


REFERENCES

  1. Boccheta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clinical Practice Epidemiology Mental Health 2006;2:23.

  2. Sadock BJ, Sadock VA. Comprehensive textbook of psychiatry. Vol. 2, 7th edition Philadelphia: Lippincott Williams Wilkins; 2000.

  3. Deodhar SD, Sing B, Pathak MC, Sharan P et al. Thyroid functions in lithium-treated psychiatric patients. Biol Trace Element Res 1998;67:151.

  4. Perrild H, Hegedus L, Baastrup PC, Kayser L et al. Thyroid function and ultrasonically determined thyroid size in patients receiving longterm lithium treatment. Am J Psychiatry 990;147:1518.

  5. Bocchetta A, Bernardi F, Pedditzi M, Loviselli A et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991;83(3):193-8.

  6. Lee S, Chow CC, Wing YK, Shek CC. Thyroid abnormalities during chronic lithium treatment in Hong Kong Chinese: a controlled study. J Affect Disord 1992;26:173-178.

  7. Bochetta A, Cherchi A, Loviselli A, Mossa P et al. Six-yearfollow- up of thyroid function during lithium treatment. Acta Psychiatr Scand 1996;94:45-48.

  8. Loviselli A, Bocchetta A, Mossa P, Velluzzi F et al. Value of thyroid echography in the long-term follow-up of lithium-treated patients. Neuropsychobiology 1997;36(1):37-41.

  9. Livingstone C, Rampes H. Lithium: A review of its metabolic adverse effects. J Psychopharmacol 2006;20:347-355.

  10. Ahmadi-Abhari SA, Ghaeli P, Fahimi F, Esfahanian F et al. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry 2003;3:4.

  11. Schoenberg M, Ts’O TOT, Meisel AN. Graves’ Disease manifesting after maintenance lithium. The J Nerv Ment Disease 1979;167(9):575-77.

  12. Reisberg B, Gershon S. Side effects associated with lithium therapy. Arch Gen Psychiatry 1979;36:879-87.

  13. Pohl R, Berchou R, Gupta BK. Case report: Lithium induced hypothyroidism and thyroiditis. Biol Psychiat 1979;14(5):835-37.

  14. Transbol I, Christiansen C, Baastrup PC. Endocrine effects of lithium. Primay Hypothyroidism, its prevalence in long term treated patıents. Acta Endocrinologica 1978;87:579-67.

  15. Kirov G. Thyroid disorders in lithum-treated patients. J Affect Disord 1998;50:33.

  16. Chow CC, Lee S, Shek CC, Wing YK et al. Lithium-associated transient thyrotoxicosis in 4 chinese woman with autoimmune thyroiditis. Aust N Z J Psychiatry 1993;27:246.

  17. Ozsoy S, Mavili E, Aydın M, Turan T et al. Ultrasonically determined thyroid volume and thyroid functions in lithium-naïve and lithiumtreated patients with bipolar disorder: a cross-sectional and longitudinal study. Human Psychopharmacology Clinical Experimental 2010;25(2):174–178.

  18. Bernstein JG. Drug therapy in psychiatry. 3rd ed., Massachusetts: Aimes Mirror Company; 1995.

  19. Tuğlular I. Psikiyatride İlaç Kullanımı. 1. Baskı, Drug use in psychiatry, 1. edition, İn İzmir. Turkish: Ege Üniversitesi Basımevi; 1991; pp. 257-298.

  20. Yüksel NY, Köroğlu E. Klinik Uygulamalı Psikofarmakoloji. 1. Baskı, Clinical Psychopharmacology. 1. Edition. Ankara, Turkish: Hekimler Yayın Birliği; 1991; pp. 160-190.

  21. Vahip S. Mood stabilizers: Lithium, carbamazepine, valproate Güleç C., Köroğlu E., Psikiyatri Temel Kitabı. Cilt 2, 1. Baskı, Ankara, Turkish: Hekimler Yayın Birliği; 1998; p. 995.

  22. Bauer M, Blumentritt H, Finke R, Schlattmann P et al. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective Isorders. J affect Disord 2007;04(1-3):45-51.

  23. Schiemann U, Hengst K. Thyroid echogenicity in manic-depressive patients receiving lithium therapy. J Affect Disord 2002;70:85-90.

  24. Akdemir A, Örsel S, Dağ İ, Turkcapar H et al. Validity, reliability and clinical use of Hamilton depression rating scale. Psikiyatri Psikoloji Psikofarmakoloji Dergisi (İn Turkish) 996;4:251-9.

  25. Karadağ F, Oral ET, Aran Yalçın F, Erten E. Validity and reliability of Young Mania Rating Scale in Turkey. Türk Psikiyatri Dergisi (İn Turkish) 2002;13:107-114.

  26. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders –clinical version (SCID-CV). Washington, DC: American Psychiatric Press; 1997.

  27. 27 Çorapçıoğlu A, Aydemir Ö, Yıldız M, Esen A et al. Structured clinical interview for DSM-IV axis I disorders –clinical version (SCID-CV) in Turkish version: Study of reliability. İlaç ve Tedavi Dergisi (in Turkish) 1999;12:233-236).

  28. Spitzer RL, Williams JBW, Gibbon M, First M. Structured clinical interview for DSM-III-R, non-patient edition (SCID-NP, Version 1.0). Washington DC: American Psychiatric Press; 1990.

  29. Sorias S, Saygılı R, Elbi H. Turkish version of structured clinical interview for DSM-III-R, non-patient edition (SCID-NP, Version 1.0), (in Turkish). Bornova: Ege Üniversitesi Basımevi; 1990;

  30. Kibirige D, Luzinda K, Ssekitoleko R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res 2013;6(1):3.

  31. Ozpoyraz N, Tamam L, Kulan E. Thyroid abnormalities in lithiumtreated patients. Adv Ther 2002;19(4):176-84.

  32. Bocchetta A, Cocco F, Velluzzi F, Del Zompo M et al. Fifteen-year follow- up of thyroid function in lithium patients. J Endocrinol Invest 2007;30(5):363-366.

  33. Ezzaher A, Haj Mouhamed D, Mechri A, Neffati F et al. Thyroid function and lipid profile in bipolar I patients. Asian J Psychiatr 2011;4(2):139-43.

  34. Bou Khalil R, Richa S. Thyroid adverse effects of psychotropic drugs: a review. Clin Neuropharmacol 2011; 34(6):248-255.

  35. Gau CS, Chang CJ, Tsai FJ, Chao PF et al. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study. Bipolar Disord 2010;12(3):253-263.

  36. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23(6):723-733.

  37. Zhang ZJ, Qiang L, Kang WH, Tan QR et al. Differences in hypothyroidism between lithium-free and -treated patients with bipolar disorders. Life Sci 2006;78(7):771-6.




2020     |     www.medigraphic.com